43 studies found for:    Open Studies | "Ureteral Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ureteral Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain
Conditions: Ureteral Obstruction;   Flank Pain
Interventions: Drug: Mirabegron;   Other: Placebo
2 Recruiting Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty
Condition: Ureteropelvic Junction Obstruction
Interventions: Other: internal Double-J stents;   Other: External Stent
3 Recruiting LCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial Cancer
Conditions: Urinary Bladder Neoplasms;   Ureteral Neoplasms;   Urethral Neoplasms
Intervention: Drug: Crizotinib
4 Not yet recruiting Lymphadenectomy in Urothelial Carcinoma
Condition: Ureteral Neoplasms [C12.758.820.875]
Interventions: Procedure: Lymphadenectomy in conjugation with nephroureterectomy;   Procedure: Nephroureterectomy without lymphadenectomy
5 Recruiting The Predictive Value of Ureteral Jet Assessment With Ultrasound in Patients Presenting With Acute Renal Colic
Condition: Ureteral Calculi
Intervention: Device: renal and bladder ultrasound with ureteral jet assessment
6 Not yet recruiting Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer
Conditions: Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage IV Bladder Urothelial Carcinoma
Interventions: Drug: ATR Kinase Inhibitor VX-970;   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Other: Laboratory Biomarker Analysis
7 Recruiting US-NCCT Real-time Fusion for Urinary Stones Follow up
Conditions: Urolithiasis;   Ureterolithiasis
Intervention: Other: Ultrasound study
8 Recruiting Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
Conditions: Malignant Reproductive System Neoplasm;   Malignant Urinary System Neoplasm;   Metastatic Urethral Neoplasm;   Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Progressive Neoplastic Disease;   Recurrent Bladder Carcinoma;   Recurrent Urethra Carcinoma;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;   Solid Neoplasm;   Stage III Bladder Urothelial Carcinoma;   Stage III Urethral Cancer;   Stage IV Bladder Urothelial Carcinoma;   Stage IV Urethral Cancer;   Urethral Urothelial Carcinoma
Interventions: Drug: Cabozantinib S-malate;   Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
9 Recruiting Treatment of Upper Ureteric Stones Ureteroscopy and Extracorporeal Shockwaves Lithotripsy (SWL) in The Management of Proximal Ureteric Stones
Condition: Ureteric Stones
Interventions: Procedure: SWL;   Procedure: Semirigid URS;   Procedure: Flexible URS
10 Recruiting Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer
Conditions: Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter;   Recurrent Bladder Carcinoma;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter;   Stage III Bladder Urothelial Carcinoma;   Stage III Urethral Cancer;   Stage IV Bladder Urothelial Carcinoma;   Stage IV Urethral Cancer;   Urethral Urothelial Carcinoma
Interventions: Drug: Pembrolizumab;   Drug: Docetaxel;   Drug: Gemcitabine Hydrochloride
11 Recruiting Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms
Condition: Renal Pelvic and Ureteral Neoplasms
Interventions: Procedure: rreversible electroporation (IRE);   Device: NanoKnife
12 Recruiting Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
Conditions: Ureteral Obstruction;   Urinary Diversion
Intervention: Procedure: Extravesical ureteral reimplantation
13 Recruiting Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
Conditions: Localized Urothelial Carcinoma of the Renal Pelvis and Ureter;   Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter;   Regional Urothelial Carcinoma of the Renal Pelvis and Ureter
Interventions: Drug: Methotrexate;   Drug: Vinblastine;   Drug: Doxorubicin Hydrochloride;   Drug: Cisplatin;   Drug: Gemcitabine Hydrochloride;   Drug: Carboplatin;   Procedure: Therapeutic Conventional Surgery;   Other: Laboratory Biomarker Analysis
14 Recruiting ESWL for Distal Ureteric Stone: Supine Versus Prone
Conditions: Urinary Tract Stones;   Urinary Stones;   Urinary Calculi
Interventions: Procedure: Supine ESWL;   Procedure: Prone ESWL;   Device: Extracorporeal Shockwave Lithotripsy (ESWL)
15 Recruiting Prospective Comparison Between Different Laser Settings for Ureteral \ Kidney Stones Treatment During Ureteroscopy
Conditions: Ureterolithiasis;   Nephrolithiasis
Intervention: Device: Ureteroscopy
16 Recruiting Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract Tumors
Conditions: Hematuria,;   Nephrolithiasis;   Cancer of Urinary Tract;   Ureteropelvic Junction Obstruction
Intervention: Device: Laser confocal microscopy
17 Recruiting Ultrasound Imaging of Kidney Stones and Lithotripsy
Conditions: Kidney Stones;   Nephrolithiasis;   Urolithiasis;   Ureter Stones
Intervention: Device: Verasonics Data Acquisition System (VDAS)
18 Recruiting Trial Comparing Relapse Rates Between Standard Ureteroscopic Removal Of Ureteral Stone And Standard Removal With Additional Ureterorenic Clearing Of Non-Symptomatic Stones In The Kidney
Condition: Ureteral Stones
Interventions: Procedure: Ureteral stone removal;   Procedure: Asymptomatic kidney stones and ureteral stone removed
19 Recruiting Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery
Conditions: Metastatic Ureteral Neoplasm;   Metastatic Urethral Neoplasm;   Stage III Bladder Urothelial Carcinoma;   Stage III Ureter Cancer;   Stage III Urethral Cancer;   Stage IV Bladder Urothelial Carcinoma;   Stage IV Ureter Cancer;   Stage IV Urethral Cancer;   Ureter Urothelial Carcinoma;   Urethral Urothelial Carcinoma
Interventions: Drug: Eribulin Mesylate;   Drug: Gemcitabine Hydrochloride
20 Recruiting Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal
Conditions: Disorder of Urinary Stent;   Ureteral Spasm;   Ureteropelvic Junction Obstruction;   Urolithiasis
Interventions: Drug: Ibuprofen;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years